Liver ID3ntity | Unravelling the molecular basis of the Kupffer cell-hepatocyte crosstalk and its role in the functional specialization of liver Kupffer cells.

Summary
Macrophages perform unique tissue-specific functions that are essential for the homeostasis of each organ. To perform these tissue-specific functions, each resident macrophage expresses a relatively unique gene expression profile controlled by specific transcription factors. Kupffer cells (KCs) are the biggest macrophage population of the body and represent 10% of all liver cells. The Guilliams lab recently reported that each KC projects an important part of its body across the liver endothelial cell barrier to be in close contact with hepatocytes. We have established that the transcription factor ID3 is highly expressed in murine KCs as compared to other macrophages, is highly preserved in KCs across 5 different species and is essential for controlling KC identity in vivo. We have recently reported that monocytes co-cultured with hepatocytes, but not with liver endothelial cells or liver fibroblasts, acquire strong ID3 expression, indicating that hepatocyte-derived signals induce ID3 expression. The objective of this proposal is to utilise ID3-expression in KCs to unravel the molecular mechanisms underlying the KC-Hepatocyte crosstalk. Since nothing is known about the hepatocyte-derived signals that induce ID3 expression in myeloid cells, I will utilize a genome-wide in vitro CRISPR screen to identify positive and negative regulators of the ID3 expression induced by hepatocytes. The result of this in vitro ID3-screen will then be combined with potential regulators predicted through epigenetic and ligand-receptor inference algorithms, to obtain our top candidates for genes involved in the liver KC-Hepatocyte crosstalk. Using cutting-edge technology combining direct guide-RNA capture with single-cell RNA sequencing, I will then perform a targeted in vivo CRISPR screen. Finally, I will knock-down the most interesting hits from this in vivo screen using CRE-Lox technology to understand the role of specific KC-Hepatocyte interactions in liver homeostasis and pathology.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/101030055
Start date: 01-05-2021
End date: 30-06-2023
Total budget - Public funding: 166 320,00 Euro - 166 320,00 Euro
Cordis data

Original description

Macrophages perform unique tissue-specific functions that are essential for the homeostasis of each organ. To perform these tissue-specific functions, each resident macrophage expresses a relatively unique gene expression profile controlled by specific transcription factors. Kupffer cells (KCs) are the biggest macrophage population of the body and represent 10% of all liver cells. The Guilliams lab recently reported that each KC projects an important part of its body across the liver endothelial cell barrier to be in close contact with hepatocytes. We have established that the transcription factor ID3 is highly expressed in murine KCs as compared to other macrophages, is highly preserved in KCs across 5 different species and is essential for controlling KC identity in vivo. We have recently reported that monocytes co-cultured with hepatocytes, but not with liver endothelial cells or liver fibroblasts, acquire strong ID3 expression, indicating that hepatocyte-derived signals induce ID3 expression. The objective of this proposal is to utilise ID3-expression in KCs to unravel the molecular mechanisms underlying the KC-Hepatocyte crosstalk. Since nothing is known about the hepatocyte-derived signals that induce ID3 expression in myeloid cells, I will utilize a genome-wide in vitro CRISPR screen to identify positive and negative regulators of the ID3 expression induced by hepatocytes. The result of this in vitro ID3-screen will then be combined with potential regulators predicted through epigenetic and ligand-receptor inference algorithms, to obtain our top candidates for genes involved in the liver KC-Hepatocyte crosstalk. Using cutting-edge technology combining direct guide-RNA capture with single-cell RNA sequencing, I will then perform a targeted in vivo CRISPR screen. Finally, I will knock-down the most interesting hits from this in vivo screen using CRE-Lox technology to understand the role of specific KC-Hepatocyte interactions in liver homeostasis and pathology.

Status

SIGNED

Call topic

MSCA-IF-2020

Update Date

28-04-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.1. EXCELLENT SCIENCE
H2020-EU.1.3. EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions (MSCA)
H2020-EU.1.3.2. Nurturing excellence by means of cross-border and cross-sector mobility
H2020-MSCA-IF-2020
MSCA-IF-2020 Individual Fellowships